BlueRockers collected 86 pair of prescription and non-prescription glasses for the Lions Club as part of October's Vision Month and #WorldSightDay. These items will be distributed to visually impaired adults and children in communities around the world who are underserved in eye health services. Learn more about our ophthalmology program: https://lnkd.in/e5UHNxCT #Ophthalmology #Community
BlueRock Therapeutics
生物技术研究
Cambridge，Massachusetts 65,277 位关注者
Striving to transform the treatment of disease by harnessing the power of cell therapy
关于我们
BlueRock Therapeutics is a leading engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. BlueRock Therapeutics’ cell+gene platform harnesses the power of cells to create new medicines for neurology, cardiology, and immunology indications. BlueRock Therapeutics’ cell differentiation technology recapitulates the cell’s developmental biology to produce authentic cell therapies, which are further engineered for additional function. Utilizing these cell therapies to replace damaged or degenerated tissue brings the potential to restore or regenerate lost function. BlueRock’s culture is defined by scientific innovation, the highest ethical standards and an urgency to bring transformative treatments to all who would benefit. The company strives to be a top employer of scientific talent, empowering every member of the team to make meaningful and lasting contributions to the burgeoning field of regenerative medicine. Become a BlueRocker! We are expanding our BlueRock team at all locations. Contact us via LinkedIn or our website to learn about rewarding career opportunities.
- 网站
-
https://www.bluerocktx.com
BlueRock Therapeutics的外部链接
- 所属行业
- 生物技术研究
- 规模
- 201-500 人
- 总部
- Cambridge，Massachusetts
- 类型
- 私人持股
- 创立
- 2016
- 领域
- Stem Cell Therapeutics、Engineered Cell Therapy、Cardiology、Neurology、Immunology、Regenerative Medicine和Cell+Gene
地点
BlueRock Therapeutics员工
动态
-
"You have to realize that you need to be cared for, too, and the one whose going to make sure that happens, is you." - Patsy Ponder Dalton Listen to Patsy's experience on the Foundation's podcast: https://lnkd.in/ej6N2HcY Thank you, caregivers, for all that you do.
November is National Caregivers Month! This month and beyond, we honor the dedication and compassion of care partners in the Parkinson’s community. Your strength, love, and support truly inspire us. ?? Know that the Parkinson’s Foundation is here for you with resources at each stage of your care partner journey. Explore Parkinson.org/CarePartners to learn more and stay tuned on social media as we highlight resources to empower caregivers to find balance. #CaregiversMonth #Together4PD
-
-
President and Chief Executive Officer at BlueRock Therapeutics | Driven by a personal mission to bring impactful therapies to patients and inspire the teams who develop them
Today, along with my Bayer colleague Sybil Williams, I had the pleasure of co-hosting Berlin’s Mayor Kai Wegner at the Bayer Research and Innovation Center (BRIC) in Cambridge. Mayor Wegner is leading a U.S. tour of government and business leaders from Berlin that are focused on connecting Berlin based healthcare companies with U.S. based companies and institutions. It was great to talk with the Mayor and this group about the work BlueRock Therapeutics is doing in #CellTherapy to help patients with #ParkinsonsDisease and #PrimaryPhotoreceptorDisease, as well as to showcase the robust and diverse life sciences ecosystem in Cambridge/Boston. #TeamBayer
-
-
Happy National STEM Day! Many of our BlueRockers were inspired and motivated to pursue STEM careers thanks to incredible educators in their lives. Who inspired you to pursue a career in #STEM?
-
President and Chief Executive Officer at BlueRock Therapeutics | Driven by a personal mission to bring impactful therapies to patients and inspire the teams who develop them
Today I joined the Financial Times for a panel on #Neuroscience innovation and investment. Great to hear perspectives from Kylie Bromley, Kabir Nath, and expert moderation by Oliver Barnes. I love exploring the various intersections of neuroscience, mental health, and how we can make an impact on people's lives. #ParkinsonsDisease Endpoints News
-
-
We are #BlueRockers. Learn more about our mission and values: https://lnkd.in/d-gG_XYX
-
We #BooRockers take Halloween very seriously!
-
-
-
-
-
+2
-
-
VISION AWARENESS MONTH: In January, BlueRock and Foundation Fighting Blindness announced a collaboration to add a new cohort to the Foundation’s Uni-Rare natural history study of people living with inherited retinal diseases caused by rare single gene mutations. Read more about the collaboration: https://lnkd.in/eCJPJyGf #Ophthalmology #Collaboration
-
-
#TeamBlueRock so enjoyed speaking with everyone in attendance at the Parkinson's Foundation Moving Day Walk on the beautiful Charles River. Great to see so many people from the Parkinson's community out raising money for an excellent cause! #ParkinsonsDisease #Community
-
-
Our ophthalmology indications, primary photoreceptor diseases, are a subgroup of inherited retinal disorders that includes retinitis pigmentosa and cone-rod dystrophies. These diseases affect the structure and function of the photoreceptor cells in the retina, leading to irreversible vision loss in both children and adults. ? ? BlueRockers were able to temporarily experience how vision loss affects daily life with a unique experience room. Participants could use specially made goggles that simulate vision loss associated with advanced RP and cone-rod dystrophies to understand first-hand what it's like to navigate the world. ? ? #Ophthalmology?